Ginkgo Bioworks (DNA) and Invaio Sciences, an agricultural biotechnology company leading in nature-positive crop protection solutions, announced a collaboration to develop strains that can efficiently manufacture peptide-based crop protection inputs. Growers are seeking inputs that protect agricultural crops from pests that are increasingly resistant to conventional chemistry. In response, Invaio’s platform discovers and develops peptide-based crop protection solutions that complement or offer potent alternatives to conventional chemistry while meeting growers’ standards for efficacy, affordability, and ease of use. As a part of the commercialization of its peptide-based products, Invaio will leverage Ginkgo’s platform and best-in-class microbial strains for protein production. Ginkgo’s strains have been engineered to provide advanced starting points for protein and peptide-based products through industrial-scale fermentation. In this collaboration, Ginkgo will further optimize its strains and fermentation processes to deliver on Invaio’s production goals.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- OpenAI says worked with Ginkgo on autonomous lab
- Ginkgo Bioworks jumps after OpenAI comment on working together
- Private Markets: Anthropic raising $10B at $350B valuation
- Ginkgo Bioworks price target lowered to $12 from $14 at TD Cowen
- Ginkgo Bioworks price target lowered to $12 from $142 at TD Cowen
